F/m Emerald Life Sciences Innovation ETF · Other
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, F/m Emerald Life Sciences Innovation ETF (LFSC) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | TVTX | 7.67% | $8M |
| 2 | COGT | 7.53% | $8M |
| 3 | LIVN | 7.11% | $7M |
| 4 | SYRE | 6.41% | $7M |
| 5 | GH | 5.52% | $6M |
| 6 | MIRM | 4.92% | $5M |
| 7 | CORT | 4.79% | $5M |
| 8 | UTHR | 4.16% | $4M |
| 9 | MANE | 3.42% | $4M |
| 10 | SVRA | 3.22% | $3M |
| 11 | CYTK | 3.16% | $3M |
| 12 | NKTR | 3.14% | $3M |
| 13 | TRVI | 3.12% | $3M |
| 14 | DNTH | 3.09% | $3M |
| 15 | AXSM | 2.84% | $3M |
| 16 | BLLN | 2.73% | $3M |
| 17 | TMDX | 2.68% | $3M |
| 18 | VRDN | 2.23% | $2M |
| 19 | ICUI | 2.09% | $2M |
| 20 | CRVS | 1.95% | $2M |
| 21 | PVLA | 1.95% | $2M |
| 22 | CBLL | 1.55% | $2M |
| 23 | GMED | 1.27% | $1M |
| 24 | XERS | 1.22% | $1M |
| 25 | BBIO | 1.17% | $1M |
Showing 25 of 38 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
Daily range, ATR, beta, and the math for a 1-ADR stop.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LFSC Jan avg: 4.64% median: 4.64% win: 50% σ: 10.32% n: 2 2024-11-01 → 2026-07-31 | LFSC Feb avg: -2.06% median: -2.06% win: 50% σ: 5.84% n: 2 2024-11-01 → 2026-07-31 | LFSC Mar avg: -6.21% median: -6.21% win: 0% σ: 3.37% n: 2 2024-11-01 → 2026-07-31 | LFSC Apr avg: 5.61% median: 5.61% win: 100% σ: 4.35% n: 2 2024-11-01 → 2026-07-31 | LFSC May avg: 1.59% median: 1.59% win: 50% σ: 2.82% n: 2 2024-11-01 → 2026-07-31 | LFSC Jun avg: 11.07% median: 11.07% win: 100% σ: 5.22% n: 2 2024-11-01 → 2026-07-31 | LFSC Jul avg: -0.42% median: -0.42% win: 50% σ: 1.68% n: 2 2024-11-01 → 2026-07-31 | LFSC Aug avg: 15.05% median: 15.05% win: 100% σ: 0.00% n: 1 2024-11-01 → 2026-07-31 (current) | LFSC Sep avg: 6.69% median: 6.69% win: 100% σ: 0.00% n: 1 2024-11-01 → 2026-07-31 | LFSC Oct avg: 10.54% median: 10.54% win: 100% σ: 0.00% n: 1 2024-11-01 → 2026-07-31 | LFSC Nov avg: 10.64% median: 10.64% win: 100% σ: 6.64% n: 2 2024-11-01 → 2026-07-31 | LFSC Dec avg: -7.36% median: -7.36% win: 0% σ: 5.57% n: 2 2024-11-01 → 2026-07-31 |
Position changes from the to the N-PORT filing.
| Holding | Before → after | Δ weight |
|---|---|---|
| MANEVeraDermics Inc | — → 3.42% | — |
| DNTHDianthus Therapeutics Inc | — → 3.09% | — |
| VRDNViridian Therapeutics Inc | — → 2.23% | — |
| PVLAPalvella Therapeutics Inc | — → 1.95% | — |
| TWSTTwist Bioscience Corp | — → 1.14% | — |
+1 more
| Holding | Before → after | Δ weight |
|---|---|---|
| CORTCorcept Therapeutics Inc | 1.52% → 4.79% | +3.28 pp |
| TVTXTravere Therapeutics Inc | 4.63% → 7.67% | +3.04 pp |
| SYRESpyre Therapeutics Inc | 4.41% → 6.41% | +2.00 pp |
| CYTKCytokinetics Inc | 1.38% → 3.16% | +1.78 pp |
| BLLNBilliontoone Inc | 1.33% → 2.73% | +1.41 pp |
+7 more
| Holding | Before → after | Δ weight |
|---|---|---|
| TMDXTransMedics Group Inc | 5.26% → 2.68% | −2.58 pp |
| COGTCogent Biosciences Inc | 9.05% → 7.53% | −1.52 pp |
| BBIOBridgebio Pharma Inc | 2.56% → 1.17% | −1.39 pp |
| ITGRInteger Holdings Corp | 2.18% → 1.14% | −1.04 pp |
| ICUIICU Medical Inc | 3.03% → 2.09% | −0.94 pp |
+14 more
| Holding | Before → after | Δ weight |
|---|---|---|
| KALVKalVista Pharmaceuticals Inc | 3.81% → — | — |
| ACADACADIA Pharmaceuticals Inc | 2.44% → — | — |
| COLLCollegium Pharmaceutical Inc | 2.06% → — | — |
| MDGLMadrigal Pharmaceuticals Inc | 1.76% → — | — |
| SLNOSoleno Therapeutics Inc | 1.06% → — | — |
+1 more
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Holdings of LFSC currently on TickerStance stock-RS leaderboards.
Metrics matched 37 tickers across 38 holdings rows (98.0% of fund weight). Metrics as of 2026-08-24; holdings from the filing.